StockStory.org on MSN
2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes.
Tempus AI's diagnostics segment shows strong pricing power, with Oncology ASP rising from $1,630 to over $2,200. Read why TEM ...
Non-protein-coding genes have been linked to a hereditary condition, retinitis pigmentosa, that causes progressive blindness.
Treponema pallidum, a microorganism that can cause a deadly sexually transmitted disease in humans, may have a far more ancient lineage than scientists once thought ...
A new study reveals that super agers over 80 have a distinct genetic edge. They are much less likely to carry the gene most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results